Industry Experts

Paul Jaminet, Ph.D., is founder and CEO of Angiex, Inc. Angiex is developing a new class of drugs, Nuclear-Delivered Antibody-Drug Conjugates™, for therapy of solid cancers. Angiex’s lead ND-ADC, AGX101, is in Phase 1 clinical trials. Prior to Angiex, Paul created the Perfect Health Retreat and wrote the book Perfect Health Diet (Scribner, 2012). Paul began his career as an Astrophysicist at the Harvard-Smithsonian Center for Astrophysics before becoming a software entrepreneur during the Internet boom. He has founded four companies and advised 13. He holds a Ph.D. in physics from the University of California at Berkeley and B.S. degrees in physics and philosophy from the Massachusetts Institute of Technology.